iPSC-MSC

N/A

Report date: 2025/01/26 19:28:21

Base Information

Drug NameiPSC-MSC
Drug Alias NameiPSC-MSC (Oncoinsight)induced pluripotent stem cell-derived mesenchymal stem cell therapy (Oncoinsight)OI-401
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoinsight Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOncoinsight Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A